Sort
46,585 grants matching “heart failure”
High Shear Stress Alters Gene Regulation in Pulmonary Arterial Hypertension
$724,799Marlene Rabinovitch · Stanford University · R01 · FY2024 · HL
Exploring the origins of myelin abnormalities in normal ageing and in vascular dementia
$724,723Brian J Popko · Northwestern University At Chicago · R01 · FY2024 · AG
Disparities in Transition of Care after Acute Stroke Hospitalization: The Transition of Care Stroke Disparity Study (TCSD-S)
$724,673Ralph Lewis Sacco · University Of Miami School Of Medicine · R01 · FY2018 · MD
Elucidation of the Influence of Sleep Apnea on Risk of Atrial Fibrillation
$724,618Reena Mehra · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · HL
Clinical and Genetic Correlates of Vascular Function in African Americans: JHS
$724,579Ervin R Fox · University Of Mississippi Med Ctr · R01 · FY2014 · HL
Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair
$724,543Wuqiang Zhu · Mayo Clinic Arizona · R01 · FY2025 · HL
Blood Pressure and Kidney Function - SPRINT vs Electronic Health Record Data
$724,462Paul Englund Drawz · University Of Minnesota · R01 · FY2020 · HL
Gene and Cell Therapy of Duchenne Muscular Dystrophy
$724,448Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · U54 · FY2007 · AR
Optimizing Atrial Fibrillation Management in CKD
$724,394Nisha Bansal · University Of Washington · R01 · FY2021 · HL
Hit-to-lead optimization for heart failure drug discovery
$724,316Lennane Michel Espinoza-Fonseca · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Hit-to-lead optimization for heart failure drug discovery
$724,316Lennane Michel Espinoza-Fonseca · University Of Michigan At Ann Arbor · R01 · FY2021 · HL
Hit-to-lead optimization for heart failure drug discovery
$724,316Lennane Michel Espinoza-Fonseca · University Of Michigan At Ann Arbor · R01 · FY2019 · HL
Hit-to-lead optimization for heart failure drug discovery
$724,316Lennane Michel Espinoza-Fonseca · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
TREATMENT OF FUNCTIONAL IMPAIRMENT IN PATIENTS WITH HEART FAILURE AND COMORBID DE
$724,310Kenneth E Freedland · Washington University · R01 · FY2011 · HL
Promoting Equity via Change in Practice for Respiratory Failure (PRECIPICE)
$724,310Mari Armstrong-Hough · New York University · R01 · FY2022 · HL
Molecular examination of mitochondrial calcium control
$724,276Jeffery D Molkentin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL
Injectable Biomaterial for Treating Hypoplastic Left Heart Syndrome
$724,183Michael E Davis · Emory University · R01 · FY2022 · HL
Role of S-Nitrosylation on Beta-Adrenergic Signaling in Cardiac Injury and Repair
$724,176Walter J Koch · Duke University · R01 · FY2024 · HL
Biological substrate modification to suppress ventricular arrhythmias in a porcine model of chronic ischemic cardiomyopathy
$724,148James F. Dawkins · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Plasticity of nTS output neurons in acute and chronic hypoxia
$724,147David Douglas Kline · University Of Missouri-Columbia · R01 · FY2022 · HL
Catheter Ablation versus Antiarrythmic Drug Therapy for Atrial Fibrilllation Tria
$724,121Douglas L Packer · Mayo Clinic Rochester · U01 · FY2009 · HL
Twitter and Cardiovascular Health
$724,114Raina Merchant · University Of Pennsylvania · R01 · FY2017 · HL
Endothelial Rap1 in the control of heart function
$724,029Magdalena Chrzanowska · Versiti Wisconsin, Inc. · R01 · FY2024 · HL
Adipose Dysfunction, Imaging, Physiology, and Outcomes with SGLT2i's for Sleep Apnea: The ADIPOSA Study
$723,970Ian Jason Neeland · Case Western Reserve University · R01 · FY2023 · HL
Targeting Mitochondria in Single Ventricle Heart Disease
$723,914Shelley Deanne Miyamoto · University Of Colorado Denver · R01 · FY2021 · HL